首页 | 本学科首页   官方微博 | 高级检索  
检索        

闪式提取猴头菌-地龙生物转化物中抗凝血活性成分的工艺研究
引用本文:陈光宇,何述金,周代俊,周邦维,何群.闪式提取猴头菌-地龙生物转化物中抗凝血活性成分的工艺研究[J].中国现代应用药学,2018,35(11):1698-1701.
作者姓名:陈光宇  何述金  周代俊  周邦维  何群
作者单位:湖南中医药大学中医诊断研究所, 长沙 410208;湖南省药食同源功能性食品工程技术研究中心, 长沙 410208,湖南新汇制药股份有限公司, 长沙 410200,湖南新汇制药股份有限公司, 长沙 410200,湖南新汇制药股份有限公司, 长沙 410200,湖南省药食同源功能性食品工程技术研究中心, 长沙 410208;中药成药性与制剂制备湖南省重点实验室, 长沙 410208
基金项目:湖南中医药大学校企合作科研项目(KJC20150324)
摘    要:目的 优选闪式提取猴头菌-地龙生物转化物(Hericium erinaceus-Pheretima biotransformation,HD)中抗凝血活性成分工艺参数。方法 以活化部分凝血酶时间为评价指标,以水作提取溶剂,提取2次,通过响应面设计试验法,对闪式提取HD中抗凝血活性成分的主要工艺参数进行优化。结果 闪式提取HD中抗凝血活性成分的最优工艺条件为:提取2次,第1次提取加水12倍,5 500 r·min-1提取7 min;第2次提取加水10倍,5 500 r·min-1提取7 min。在此工艺条件下所制备提取液的活化部分凝血酶时间均值最高,为(53.42±3.02)s。结论 通过优化与验证,首次创立了闪式提取HD中抗凝血活性成分的工艺路线。该工艺提取速度快,提取溶剂无毒,提取设备操作简单、所占空间小,节约资源。

关 键 词:猴头菌-地龙生物转化物  抗凝血活性成分  闪式提取法  活化部分凝血酶时间  响应曲面设计试验法
收稿时间:2018/2/24 0:00:00

Research on the Process of Homogenate Extraction Anticoagulant Components from Hericium Erinaceus-Pheretima Biotransformation
CHEN Guangyu,HE Shujin,ZHOU Daijun,ZHOU Bangwei and HE Qun.Research on the Process of Homogenate Extraction Anticoagulant Components from Hericium Erinaceus-Pheretima Biotransformation[J].The Chinese Journal of Modern Applied Pharmacy,2018,35(11):1698-1701.
Authors:CHEN Guangyu  HE Shujin  ZHOU Daijun  ZHOU Bangwei and HE Qun
Institution:Institute of TCM Diagnostics, Hunan University of Chinese Medicine, Changsha 410208, China;Engineering Center of Medicinal and Edible Functional Food, Hunan University of Chinese Medicine, Changsha 410208, China,Xin Hui Pharmaceutical Co., Ltd., Changsha 410200, China,Xin Hui Pharmaceutical Co., Ltd., Changsha 410200, China,Xin Hui Pharmaceutical Co., Ltd., Changsha 410200, China and Engineering Center of Medicinal and Edible Functional Food, Hunan University of Chinese Medicine, Changsha 410208, China;Hunan Provincial Key Laboratory of Properties of Chinese Patent Medicine and Preparation, Changsha 410208, China
Abstract:OBJECTIVE To optimize process parameters of homogenate extraction anticoagulant components from Hericium erinaceus-Pheretima biotransformation (HD). METHODS The activated partial thromboplastin time (APTT) was used as the assessment index. Water was selected as extracting solvent, extracted 2 times. These main factors in the process of homogenate extraction anticoagulant components from HD which had effect on the APTT were optimized through response surface methodology. RESULTS The optimum process parameters of homogenate extraction anticoagulant components from HD were as follows:extracted 2 times, the additive quantity of water was 12 times at the first times, the extracting time was 7 min, the revolution was 5 500 r·min-1, the additive quantity of water was 10 times at the second times, the extracting time was 7 min, the revolution was 5 500 r·min-1. Under these conditions, the average value of APTT was the maximum, came up to (53.42±3.02)s. CONCLUSION A new process route of homogenate extraction anticoagulant components from HD has been established by optimization and verification experiment at the first time. The process is faster, healthier, simpler, and the equipment is smaller area occupied and save resources.
Keywords:Hericium erinaceus-Pheretima Biotransformation (HD)  anticoagulant component  homogenate extraction  activated partial thromboplastin time (APTT)  response surface methodology
点击此处可从《中国现代应用药学》浏览原始摘要信息
点击此处可从《中国现代应用药学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号